The potential role of gene expression in the management of primary and metastatic colorectal cancer

Cancer Control

Volumn 13, Issue 1, 2006, Pages 27-31

  Alvarado, Michael D ^a   Jensen, Eric H ^a   Yeatman, Timothy J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; RNA;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLUSTER ANALYSIS; COLORECTAL CANCER; DNA MICROARRAY; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; LIVER METASTASIS; LYMPH NODE METASTASIS; MEDICAL RESEARCH; METASTASIS; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATIENT CODING; PATIENT SELECTION; PREDICTION; PROGNOSIS; TREATMENT OUTCOME; UNINDEXED SEQUENCE; UPREGULATION;

EID: 33644638667     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480601300104     Document Type: Article

References (20)

1. Steele G, Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989;210:127-138.
2. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
3. Yamaguchi A, Kurosaka Y, Kanno M, et al. Analysis of hepatic recurrence of colorectal cancer after resection of hepatic metastases. Int Surg. 1993;78:16-19.
4. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-321.
5. Jenkins LT, Millikan KW, Bines SD, et al. Hepatic resection for metastatic colorectal cancer. Am Surg. 1997;63:605-610.
6. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438-450.
7. Bonner RF, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science. 1997;278:1481-1483.
8. King HC, Sinha AA. Gene expression profile analysis by DNA microarrays: promise and pitfalls. J AMA. 2001;286:2280-2288.
9. Hurwitz H. Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin Colorectal Cancer. 2004;4(suppl 2):S62-S68.
10. Adam R, Avisar E, Ariche A, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol. 2001;8:347-353.
11. Arango D, Wilson AJ, Shi Q, et al. Molecular mechanisms of action and prediction of response to oxaliplatin in colorectal cancer cells. Br J Cancer. 2004;91:1931-1946.
12. Mariadason JM, Arango D, Shi Q, et al. Gene expression profiling-based prediction of response of colon carcinoma cells to 5-fluorouracil and camptothecin. Cancer Res. 2003;63:8791-8812.
13. Compagni A, Christofori G. Recent advances in research on multi-stage tumorigenesis. Br J Cancer. 2000;83:1-5.
14. Krajewska M, Kim H, Kim C, et al. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers. Clin Cancer Res. 2005;11:5451-5461.
15. Huerta S, Harris DM, Jazirehi A, et al. Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol. 2003;22:663-670.
16. Ramaswamy S, Tamayo P, Rifkin R, et al. Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A. 2001;98:15149-15154. Epub 2001 Dec 11.
17. Hegde P, Qi R, Gaspard R, et al. Identification of tumor markers in models of human colorectal cancer using a 19,200-element complementary DNA microarray. Cancer Res. 2001;61:7792-7797.
18. Li M, Lin YM, Hasegawa S, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol. 2004;24:305-312.
19. Bandres E, Catalan V, Sola I, et al. Dysregulation of apoptosis is a major mechanism in the lymph node involvement in colorectal carcinoma. Oncol Rep. 2004;12:287-292.
20. Eschrich S, Yang I, Bloom G, et al. Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol. 2005;23:3526-3535.